# DS-5565 Phase III Study for Renal Impairment in Japanese Subjects

> **NCT02607280** · PHASE3 · COMPLETED · sponsor: **Daiichi Sankyo Co., Ltd.** · enrollment: 35 (actual)

## Conditions studied

- Diabetic Peripheral Neuropathic Pain
- Post-herpetic Neuralgia

## Interventions

- **DRUG:** DS-5565

## Key facts

- **NCT ID:** NCT02607280
- **Lead sponsor:** Daiichi Sankyo Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-12
- **Primary completion:** 2017-03
- **Final completion:** 2017-03
- **Target enrollment:** 35 (ACTUAL)
- **Last updated:** 2021-05-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02607280

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02607280, "DS-5565 Phase III Study for Renal Impairment in Japanese Subjects". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02607280. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*